Cash Flow from Financial Activities (Quarterly)

Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.

Biogen Inc. (BIIB) had Cash Flow from Financial Activities of $-439.60M for the most recently reported fiscal quarter, ending 2024-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2024-03-31

Income Statement Financials
Revenue	$2.29B
Net Income	$393.40M
Cost of Goods Sold	$542.20M
Gross Profit	$1.75B
Operating Expenses	$1.73B
Operating Income	$558.50M
Non-Operating Income/Expense	$-93.70M
Pre-Tax Income	$464.80M
Normalized Pre-Tax Income	$464.80M
Income after Taxes	$393.40M
Income from Continuous Operations	$393.40M
Consolidated Net Income/Loss	$393.40M
Normalized Income after Taxes	$393.40M
EBIT	$558.50M
EBITDA	$750.10M
Weighted-Average Shares Outstanding (Basic)	145.20M
Weighted-Average Shares Outstanding (Diluted)	145.90M
Earnings per Share (EPS) (Basic)	$2.71
Earnings per Share (EPS) (Diluted)	$2.70
Balance Sheet Financials
Current Assets	$6.76B
Property, Plant, and Equipment	$3.28B
Long-Term Assets	$19.81B
Total Assets	$26.57B
Current Liabilities	$3.22B
Long-Term Debt	$6.29B
Long-Term Liabilities	$8.13B
Total Liabilities	$11.35B
Common Equity	$15.21B
Tangible Shareholders Equity	$700.90M
Shareholders Equity	$15.21B
Common Shares Outstanding	145.60M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$553.20M
Cash Flow from Investing Activities	$-66.00M
Cash Flow from Financial Activities	$-439.60M
Beginning Cash	$1.05B
End Cash	$1.07B
Increase/Decrease in Cash	$24.50M
Stock-Based Compensation	$72.80M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.10
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.29
Debt to Equity Ratio	0.43
Gross Margin	76.33%
Operating Margin	24.38%
EBIT Margin	24.38%
EBITDA Margin	--
Pre-Tax Profit Margin	20.29%
Profit Margin	17.18%
Free Cash Flow	$507.30M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.09
Inventory Turnover	0.22
Receiveable Turnover	1.15
Days Sales in Receivables	78.57
Return on Equity	2.59%
Return on Tangible Equity	56.13%
Return on Assets	1.48%
Return on Investments	1.83%
Book Value Per Share	$104.48
Free Cash Flow per Share	$3.48
Operating Cash Flow per Share	$3.79

Data from Zacks Investment Research, Inc.